Upstream Bio Revenue and Competitors
Estimated Revenue & Valuation
- Upstream Bio's estimated annual revenue is currently $3.3M per year.
- Upstream Bio's estimated revenue per employee is $77,500
- Upstream Bio's total funding is $400M.
Employee Data
- Upstream Bio has 43 Employees.
- Upstream Bio grew their employee count by 16% last year.
Upstream Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Upstream Bio?
At Upstream Bio we strive to reach the source of inflammation and conquer it. Our lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor. TSLP is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases. We are leveraging our diverse roots and the team’s substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones.
keywords:N/A
$400M
Total Funding
43
Number of Employees
$3.3M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Waltham
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 43 | 10% | N/A |
#2 | $3.5M | 43 | -9% | N/A |
#3 | $6.3M | 44 | -6% | N/A |
#4 | $9.5M | 44 | 10% | N/A |
#5 | $11.6M | 45 | -4% | N/A |